E-Paper
Mylan CEO to testify in US House over EpiPen price
WASHINGTON: Mylan NL CEO Heather Bresch will appear at a September 21 congressional hearing over price increases for its allergy auto-injector EpiPen, which are
Published on: Sep 15, 2016, 06:39:59 IST
Share via
Copy link
WASHINGTON: Mylan NL CEO Heather Bresch will appear at a September 21 congressional hearing over price increases for its allergy auto-injector EpiPen, which are carried by people with life-threatening allergies, from about $100 in 2008 to about $600.
Stay updated with the latest Business News, stock market updates, petrol and diesel prices, gold and silver rates, income tax updates and major developments from India and across the world.
